nova blog

Personalized medicine is more than matching a drug to an individual. It also means getting the dose right. Using the jinkō platform, developers can precisely simulate a therapy’s effects..

On November 9, FDA held a workshop to explore whether obese patients should be included in drug trials. If so, drug development costs and timelines would rocket...

What is a digital twin? At its most general, it’s a virtual copy of a physical object (jet engine), organism (person, animal) or process (circulation, drug metabolism), used for running simulations.

In silico modeling is emerging as an important partial alternative to animal testing.  It is likely to be better at predicting efficacy and toxicity in humans...

Curated knowledge repositories allow R&D experts to systematically capture validated information avoid flaky data or irrelevant claims, and remain alert to new developments.

Faster drug approvals based on less evidence mean new tools are needed to track cost-effectiveness. As regulators approve more drugs faster , health technology assessors are under growing pressure...

Systems and minds opened up , adjusting to a world beyond conventional trials. That world should, and increasingly does, include in silico trials .

More data, by itself, does not guarantee better results or more accurate predictions from in silico modeling. Those depend on the quality and completeness of source data, the accuracy of the...

Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of...